S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures
Authors
Keywords
-
Journal
GLIA
Volume 60, Issue 3, Pages 382-392
Publisher
Wiley
Online
2011-11-22
DOI
10.1002/glia.22272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Situ Activation of Antigen-Specific CD8+ T Cells in the Presence of Antigen in Organotypic Brain Slices
- (2014) C. Ling et al. JOURNAL OF IMMUNOLOGY
- Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
- (2011) Hye Jung Kim et al. FASEB JOURNAL
- IL-17A and TNF- Exert Synergistic Effects on Expression of CXCL5 by Alveolar Type II Cells In Vivo and In Vitro
- (2011) Y. Liu et al. JOURNAL OF IMMUNOLOGY
- Fingolimod modulates microglial activation to augment markers of remyelination
- (2011) Samuel J Jackson et al. Journal of Neuroinflammation
- Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo
- (2011) Yinghui Hu et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system
- (2010) Carolin Prodinger et al. ACTA NEUROPATHOLOGICA
- Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
- (2010) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists
- (2010) Henri Mattes et al. ChemMedChem
- CXCL5 Regulates Chemokine Scavenging and Pulmonary Host Defense to Bacterial Infection
- (2010) Junjie Mei et al. IMMUNITY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sphingosine-1-phosphate and oligodendrocytes: From cell development to the treatment of multiple sclerosis
- (2009) Rochelle P. Coelho et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod
- (2008) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- MIP-3α and MIP-1α rapidly mobilize dendritic cell precursors into the peripheral blood
- (2008) Shan He et al. JOURNAL OF LEUKOCYTE BIOLOGY
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- FTY720 modulates human oligodendrocyte progenitor process extension and survival
- (2007) Veronique E. Miron et al. ANNALS OF NEUROLOGY
- Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury
- (2007) Z. Zhang et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
- (2007) Kumlesh K. Dev et al. PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now